Trials / Conditions / Infiltrating Bladder Urothelial Carcinoma

Infiltrating Bladder Urothelial Carcinoma

9 registered clinical trials studyying Infiltrating Bladder Urothelial Carcinoma.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and S NCT03609216	Alliance for Clinical Trials in Oncology	Phase 2
Unknown	NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carc NCT03549715	Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie	Phase 1 / Phase 2
Withdrawn	Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer NCT03419130	University of California, San Francisco	Phase 2
Withdrawn	Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of M NCT03238664	University of Southern California	N/A
Withdrawn	Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer NCT02944357	Mayo Clinic	N/A
Terminated	sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer NCT02767921	University of Southern California	Phase 1
Withdrawn	Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive NCT02688348	Jonsson Comprehensive Cancer Center	N/A
Completed	Bristol Bladder Trial NCT01616875	University Hospitals Bristol and Weston NHS Foundation Trust	Phase 2
Terminated	A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder NCT01495676	Institut du Cancer de Montpellier - Val d'Aurelle	N/A